RULES WERE NOT MEANT FOR THIS BMW. There's a reason the 2 Series is so loved. Blisteringly fast, the 335-horsepower rear-wheel drive M240i Coupe sprints from 0 to 60 mph in just 4.4 seconds, or 4.2 seconds with xDrive, and handles with a steering agility and control that are incredibly precise.
Tecentriq was approved by the U.S. Food and Drug Administration (FDA) for some patients with lung cancer. PUBLISHED: OCTOBER 18, 2016. Be the first to discuss this article on CURE's forum.
Brand name: TecentriqÂ®. Atezolizumab is approved to treat urothelial carcinoma, the most common type of bladder cancer. Atezolizumab is a checkpoint inhibitor, an immunotherapy drug designed to target the PD-L1 protein on cancer cells. Cancer cells are able to use PD-L1 to send signals to the PD-1 protein on immune cells, tricking the immune cells into recognizing the cancer cells as normal.